{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:57:19Z","timestamp":1777906639786,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184.034.019"],"award-info":[{"award-number":["184.034.019"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ygyno.2025.02.018","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:11:40Z","timestamp":1741000300000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Signal transduction pathway activity in adult-type granulosa cell tumor samples"],"prefix":"10.1016","volume":"195","author":[{"given":"G.J.","family":"Brink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Groeneweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.N.","family":"Jonges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.H.","family":"Gort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.O.","family":"Witteveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2025.02.018_bb0005","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1200\/JCO.2003.10.019","article-title":"Granulosa cell tumor of the ovary","volume":"21","author":"Schumer","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2025.02.018_bb0010","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/cancers14122998","article-title":"Response to systemic therapies in ovarian adult granulosa cell tumors: a literature review","volume":"14","author":"Brink","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ygyno.2025.02.018_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.ygyno.2025.02.018_bb0025","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3390\/cancers12092660","article-title":"Signal transduction pathway activity in high-grade, serous ovarian carcinoma reveals a more favorable prognosis in tumors with low PI3K and high NF-\u03baB pathway activity: a novel approach to a long-standing enigma","volume":"12","author":"van Lieshout","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ygyno.2025.02.018_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-014-0095-1","article-title":"Notch signaling in serous ovarian cancer","volume":"7","author":"Groeneweg","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2022.01.027","article-title":"Signal transduction pathway activity in high-grade serous carcinoma, its precursors and fallopian tube epithelium","volume":"165","author":"van der Ploeg","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23170","article-title":"Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: the STAPOVER study protocol","volume":"10","author":"van der Ploeg","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tem.2004.02.005","article-title":"Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours","volume":"15","author":"Fuller","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/er.2011-0014","article-title":"Molecular pathogenesis of granulosa cell tumors of the ovary","volume":"33","author":"Jamieson","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2025.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0384-1","article-title":"The molecular mechanism of ovarian granulosa cell tumors","volume":"11","author":"Li","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"11","key":"10.1016\/j.ygyno.2025.02.018_bb0060","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-13-2515","article-title":"Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathways","volume":"74","author":"Verhaegh","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0065","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41598-018-38179-x","article-title":"Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types","volume":"9","author":"Van De Stolpe","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/cancers11030293","article-title":"Quantitative measurement of functional activity of the PI3K signaling pathway in cancer","volume":"11","author":"van de Stolpe","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ygyno.2025.02.018_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.598118","article-title":"RNA based approaches to profile oncogenic pathways from low quantity samples to drive precision oncology strategies","volume":"11","author":"Van De Stolpe","year":"2021","journal-title":"Front. Genet."},{"issue":"9","key":"10.1016\/j.ygyno.2025.02.018_bb0080","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/cncr.34661","article-title":"Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma","volume":"129","author":"Hendrikse","year":"2023","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2025.02.018_bb0085","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/cancers16112084","article-title":"Hormone receptor expression and activity for different tumour locations in patients with advanced and recurrent endometrial carcinoma","volume":"16","author":"Luijten","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ygyno.2025.02.018_bb0090","series-title":"GraphPad Software","author":"GraphPad Prism","year":"2023"},{"issue":"11","key":"10.1016\/j.ygyno.2025.02.018_bb0095","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/carcin\/bgn186","article-title":"Synergistic effects of Pten loss and WNT\/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression","volume":"29","author":"Lagu\u00eb","year":"2008","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.ygyno.2025.02.018_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2015-1103","article-title":"FOXO1\/3 and PTEN depletion in granulosa cells promotes ovarian granulosa cell tumor development","volume":"29","author":"Liu","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"13","key":"10.1016\/j.ygyno.2025.02.018_bb0105","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/0008-5472.CAN-15-3358","article-title":"Constitutive activation of PI3K in oocyte induces ovarian granulosa cell tumors","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ygyno.2016.12.016","article-title":"Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells","volume":"144","author":"Haltia","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers13030368","article-title":"In vitro systematic drug testing reveals carboplatin, paclitaxel, and Alpelisib as a potential novel combination treatment for adult granulosa cell tumors","volume":"13","author":"Roze","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2025.02.018_bb0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2024.02.029","article-title":"Alpelisib for PIK3CA-mutated advanced gynecological cancers: first clues of clinical activity","volume":"183","author":"Passarelli","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1095\/biolreprod.113.108100","article-title":"Effects of an inhibitor of the gamma-secretase complex on proliferation and apoptotic parameters in a FOXL2-mutated granulosa tumor cell line (KGN)","volume":"89","author":"Irusta","year":"2013","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ygyno.2025.02.018_bb0135","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/j.ygyno.2023.06.190","article-title":"Trial in progress: a phase two trial of nirogacestat, a gamma-secretase inhibitor, in patients with recurrent ovarian granulosa cell tumors (NCT05348356) (1284)","volume":"176","author":"Konstantinopoulos","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"17","key":"10.1016\/j.ygyno.2025.02.018_bb0140","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-20-0259","article-title":"Mutant FOXL2C134W hijacks SMAD4 and SMAD2\/3 to drive adult granulosa cell tumors","volume":"80","author":"Weis-Banke","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/MCB.01404-07","article-title":"Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice","volume":"28","author":"Pangas","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mce.2011.06.021","article-title":"Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells","volume":"356","author":"Pangas","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"27","key":"10.1016\/j.ygyno.2025.02.018_bb0155","doi-asserted-by":"crossref","first-page":"40904","DOI":"10.18632\/oncotarget.10149","article-title":"Constitutively active transforming growth factor \u03b2 receptor 1 in the mouse ovary promotes tumorigenesis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.ygyno.2025.02.018_bb0160","first-page":"343","article-title":"A novel mouse model of testicular granulosa cell tumors","volume":"24","author":"Fang","year":"2018","journal-title":"MHR"},{"issue":"23","key":"10.1016\/j.ygyno.2025.02.018_bb0165","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/cells12232717","article-title":"Sertoli cell-specific activation of transforming growth factor beta receptor 1 leads to testicular granulosa cell tumor formation","volume":"12","author":"Fang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ygyno.2025.02.018_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791272","article-title":"Transforming growth factor-beta (TGF-\u03b2) signaling in cancer-a betrayal within","volume":"13","author":"Baba","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.018_bb0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2018.05.013","article-title":"Estrogen receptor \u03b2: potential target for therapy in adult granulosa cell tumors?","volume":"150","author":"Ciucci","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.02.018_bb0180","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa034","article-title":"Functional profiling of FSH and estradiol in ovarian granulosa cell tumors","volume":"4","author":"Haltia","year":"2020","journal-title":"J. Endocrine Soc."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.5843","article-title":"Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ER\u03b1-dependent mechanism","volume":"256","author":"Cluzet","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2025.02.018_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105418","article-title":"Estrogen regulates forkhead transcription factor 2 to promote apoptosis of human ovarian granulosa-like tumor cells","volume":"194","author":"Wu","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.ygyno.2025.02.018_bb0195","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1002\/jcp.30305","article-title":"TGF-\u03b21 stimulates aromatase expression and estradiol production through SMAD2 and ERK1\/2 signaling pathways in human granulosa-lutein cells","volume":"236","author":"Cheng","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.018_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12672-011-0069-3","article-title":"Nuclear receptor profiling of ovarian granulosa cell tumors","volume":"2","author":"Alexiadis","year":"2011","journal-title":"Hormones and Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2025.02.018_bb0205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/09513590.2022.2123914","article-title":"IL23 suppresses proliferation and promotes apoptosis of human granulosa-like tumor cell line KGN by targeting the androgen receptor signal pathway","volume":"38","author":"Wang","year":"2022","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.02.018_bb0210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/1078-0432.CCR-15-0534","article-title":"MAPK activation predicts poor outcome and the MEK inhibitor, selumetinib, reverses antiestrogen resistance in ER-positive high-grade serous ovarian cancer","volume":"22","author":"Hew","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2025.02.018_bb0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ijc.10746","article-title":"Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma","volume":"102","author":"Denkert","year":"2002","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:21:35Z","timestamp":1777641695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582500054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S009082582500054X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signal transduction pathway activity in adult-type granulosa cell tumor samples","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}